Key result
Labelling myosin with IATR dose-dependently reduces active contraction force in rabbit muscle fibers.
Why the study?
Labelling the fast-reacting thiol (Cys707) in myosin reduced force output during active contraction, but the structural mechanism explaining this reduction remained unknown.
Structural modeling reveals that labelling the SH1 thiol of myosin with IATR physically blocks the power stroke, explaining historical observations of reduced force output in labelled muscle fibres.
Requires caution in IATR-labelled myosin contraction studies; challenges consensus that SH1 thiol probe attachment is functionally neutral.
The fast-reacting thiol in the SH1 helix of myosin was often used to attach spin or fluorescent probes to the motor domain, to readout myosin orientation during the 1980s. However, at this time, we found that labelling this residue (Cys707) in myosin in skinned rabbit psoas fibres, using iodoacetacetamidotetramethyl rhodamine (IATR), reduced force output during active contraction. With access to recent pre- and post-powerstroke actomyosin structures, we can now explain these results. We modelled IATR onto the equivalent SH1 cysteine residue in the pre-power and post-power structures of myosin 5. This revealed that labelling of the fast-reacting thiol would interfere with the structural changes in the relay and SH1 helices required to generate the power stroke, explaining why force output reduces.
No takes yet. Share an insight, caveat, or question.
Carrington et al. (2026) reported a review. Iodoacetacetamidotetramethyl rhodamine (IATR) labelling of myosin vs. Unlabelled control muscle fibers was evaluated on Relative force output during active contraction in single skinned rabbit psoas muscle fibers. Labelling myosin with 0 to 400 µM IATR in rabbit psoas muscle fibers reduces force output during active contraction as label concentration increases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: